An Open-label Safety Extension Study of Gevokizumab in Active Inflammatory, Erosive Osteoarthritis of the Hand
Latest Information Update: 27 Feb 2015
At a glance
- Drugs Gevokizumab (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors XOMA
- 18 Feb 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 21 Nov 2014 New trial record